"The Effects of Propofol With and Without Ketamine on Montreal Cognitive Assessment Test Results in Patients With Mood Disorders Undergoing Electroconvulsive Therapy"

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231217060435N1

Enrollment

Registered

2024-03-31

Start date

2024-04-03

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Major depressive disorder. Condition 2: Bipolar disorder. Major depressive disorder, recurrent Bipolar disorder

Interventions

Intervention 1: Intervention Group 1: After intravenous line insertion, general anesthesia is induced using intravenous propofol 1 mg/kg along with intravenous succinylcholine 20 mg and intravenous at

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients With Mood Disorders Undergoing Electroconvulsive Therapy" People with an age range of 18 to 70 years who have a primary education level and above Proficiency in Persian language

Exclusion criteria

Exclusion criteria: Previous treatment with electroshock in the last six months Neurocognitive diseases such as Alzheimer's, Parkinson's, etc History of neurological disorders such as stroke, tumor or any brain injury

Design outcomes

Primary

Measure	Time frame
The result of the Montreal test. Timepoint: In both groups, before the first session and before anesthesia, after the final and sixth session of ECT and one month after the end of the treatment, the Montreal cognitive test will be repeated. Method of measurement: Montreal Cognitive Assessment Test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Zaribaf

Shahid Beheshti University of Medical Sciences

ar.zaribaf@gmail.com+98 913 210 0551

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026